Trial record 12 of 14 for:
Provectus, PV-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02322086 |
|
Recruitment Status :
Completed
First Posted : December 22, 2014
Last Update Posted : November 13, 2017
|
Sponsor:
Provectus Pharmaceuticals
Information provided by (Responsible Party):
Provectus Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2015 |
| Actual Study Completion Date : | June 2017 |